CompanionDx, Rx Review Partner to Increase Access to PGx Testing | GenomeWeb

NEW YORK (GenomeWeb) – CompanionDx Reference Lab and Rx Review Service are partnering in an effort to increase the use of pharmacogenomics testing under a deal announced today.

Specifically, the firms seek to increase the availability of qualified pharmacogenomic testing to healthcare institutions and doctor practices in order to improve patient therapy. "The partnership provides an opportunity to grow and expand market presence, bringing the benefits of pharmacogenomic testing to the entire healthcare industry," Rx Review Service President Jerry Wanio said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.